-
Progress Report from the Cancer Immunology “Dream Team”
A group of "star" scientists are investigating new avenues of cancer immunotherapy that will benefit patients.
-
Do Something Epic in 2015!
Meet a few of the riders who will join Team CRI in the 2015 Ride to Conquer…
-
FDA Approves New Immunotherapy for Leukemia
Amgen’s Blincyto was approved by the FDA, making it the first approved bispecific T cell engaging (BiTE)…
-
AACR Report Highlights Cancer Immunotherapy
The AACR Cancer Progress Report provides a "state-of-the-union" look at where we are in cancer research.
